Data Year:

For its 2024 fiscal year, GLOBUS MEDICAL INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2024
Name And Title Total Compensation Pay Rank By Title In MFG Durable industry
David C. Paul
Chairman of the Board of Directors and Executive Chairman
Total Compensation $3,059,800 View details Pay Rank By Title In MFG Durable industry #4 View more
Daniel T. Scavilla
Chief Executive Officer and President
Total Compensation $4,858,660 View details Pay Rank By Title In MFG Durable industry #406 View more
Keith W. Pfeil
Chief Operating Officer and Chief Financial Officer
Total Compensation $2,363,278 View details Pay Rank By Title In MFG Durable industry #310 View more
Kelly G. Huller
Executive Vice President, General Counsel and Corporate Secretary
Total Compensation $1,628,623 View details Pay Rank By Title In MFG Durable industry #121 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at GLOBUS MEDICAL INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. GLOBUS MEDICAL INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. GLOBUS MEDICAL INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
David C. Paul
Chairman of the Board of Directors and Executive Chairman
Total Cash $1,456,419 Equity $1,573,332 Other $30,049 $3,059,800
Daniel T. Scavilla
Chief Executive Officer and President
Total Cash $1,885,227 Equity $2,936,886 Other $36,547 $4,858,660
Keith W. Pfeil
Chief Operating Officer and Chief Financial Officer
Total Cash $1,069,009 Equity $1,258,665 Other $35,604 $2,363,278
Kelly G. Huller
Executive Vice President, General Counsel and Corporate Secretary
Total Cash $760,901 Equity $839,110 Other $28,612 $1,628,623
For its 2024 fiscal year, GLOBUS MEDICAL INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Daniel T. Scavilla CEO Pay $4,858,660 Median Employee Pay $95,497 CEO Pay Ratio 51:1
For its 2024 fiscal year, GLOBUS MEDICAL INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Ann D. Rhoads Total Cash $441,524
Daniel J. Wolterman Total Cash $411,524
Daniel T. Lemaitre Total Cash $421,524
David D. Davidar Total Cash $421,524
James R. Tobin Total Cash $421,524
John A. DeFord Total Cash $466,896
Leslie V. Norwalk Total Cash $411,524
Robert A. Douglas Total Cash $411,524
Stephen T. Zarrilli Total Cash $411,524
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.